Assessing and Managing Metabolic Risk in Bipolar Disorder and Schizophrenia Dost Ongur, MD, PhD

Assessing and Managing Metabolic Risk in Bipolar Disorder and Schizophrenia

Education

Overview: Limitations of Current Treatment of Depression Maurizio Fava, MD

Long-Acting Injectable (LAI) Antipsychotics in Bipolar Disorder and Schizophrenia Oliver Freudenreich, MD, FAPM

Assessment and Treatment of Affective Symptoms in Schizophrenia Oliver Freudenreich, MD, FAPM

Optimal Treatment of Psychosis in Bipolar Disorder Sharmin Ghaznavi, MD, PhD